Orphan Now is a consulting and partnering organization that guides and supports orphan drug companies in their quest to develop and commercialize therapies needed by patients with rare diseases.
Orphan Now enables our orphan drug client companies to capitalize on experienced in-market senior talent and capabilities early and quickly.
We are a network of independent, highly successful rare disease business leaders and experts.
Franck Auvray is a biopharmaceuticals executive with more than twenty-five years of expertise in [..]
With a successful business career in life sciences spanning over twenty-five years, Jordi is a se [..]
Mark has more than thirty years of experience in the pharmaceutical industry, with the last fifte [..]
Pharmacist by education (Master of Science – Federal Diploma of Pharmacy, University of Lausanne, [..]
Giovanni Galliano is a pharma and biotech executive with more than thirty years of experience in [..]
Hans Peter Halbritter looks back on more than twenty-seven years of experience as a commercial bi [..]
Anders is a Medical Doctor with extensive experience in pharma/biotech, spanning rare diseases, o [..]
Robert-Jan is a results-driven biotech leader with deep expertise in supporting biotech companies [..]